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The oil-resin of Copaifera reticulata Ducke is used in the Brazilian folk medicine as an anti-inflammatory and healing agent.
However, there are no investigations on the possible anti-inflammatory and neuroprotective roles of copaiba oil-resin (COR) after
neural disorders. We have investigated the anti-inflammatory and neuroprotective eﬀects of COR following an acute damage to the
motor cortex of adult rats. Animals were injected with the neurotoxin N-Methyl-D-Aspartate (NMDA) (n = 10) and treated with a
single dose of COR (400mg/kg, i.p.) soon after surgery (Group 1) or with two daily doses (200mg/kg, i.p.) during 3 days (Group 2)
alter injury. Control animals were treated with vehicle only. COR treatment induced tissue preservation and decreased the recruit-
ment of neutrophils and microglial activation in the injury site compared to vehicle animals. The results suggest that COR treat-
ment induces neuroprotection by modulating inflammatory response following an acute damage to the central nervous system.
1. Introduction
Inflammation is involved in several diseases of both neural
and nonneural tissues [1]. After acute and chronic neural
disorders a conspicuous inflammatory response takes place
involving both humoral (i.e., immunoglobulins, cytokines)
and cellular components (neutrophils, lymphocytes, astro-
cytes, and microglia/macrophages) [2].
Following acute neural disorders, including stroke and
brain and spinal cord trauma, an intense inflammatory
reaction is elicited [2]. In these diseases, recruitment of
neutrophils and lymphocytes occurs in an early phase [3, 4]
followed by an intense microglia/macrophage activation in
latter stages [4–6].
It has been shown that both neutrophils [7–9] and acti-
vated macrophages/microglia [10] contribute to secondary
damage following experimental spinal cord injury (SCI) and
stroke, as well as in humans [11, 12]. These inflammatory
cells may release lytic enzymes, reactive oxygen species,
and proinflammatory factors, contributing to tissue damage
[13]. Experimental blockage of neutrophil recruitment with
an anti-P-selectin monoclonal antibody [14] or inhibition
of microglial activation with the semisynthetic tetracycline
minocycline [10] induces neuroprotection following acute
neural disorders. These anti-inflammatory therapies are a
promising approach for central nervous system (CNS)
human diseases [15, 16].
The copaiba oil-resin (COR) is obtained by tapping
the trunk of the trees from several Copaifera L. species
(Leguminoseae). These oleoresins have been traditionally
used as healing and anti-inflammatory agents in the Brazilian
folk medicine. Nevertheless, in recent years, several studies
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suggested a broad spectrum of COR eﬀects in nonneural tis-
sues, including anti-inflammatory and antinociceptive [17–
19], cytotoxic and anticancerous [20], antimicrobial [21],
wound healing, and antiulcer [18] activities. However, few
studies have investigated the eﬀects of COR on the nerv-
ous system [17] and mainly describe a general eﬀect of COR
treatment on CNS-mediated behaviors like anxiety [17]. So
far, there are no investigations on the COR eﬀects following
an acute damage to the CNS.
In this study, we investigated the eﬀects of COR treat-
ment on tissue preservation, neutrophil infiltration, and mi-
croglia/macrophage activation following an NMDA-induced
excitotoxic damage to the motor cortex of adult rats.
2. Material andMethods
2.1. Experimental Animals. Male adult Wistar rats were ob-
tained from the Central Animal Facility of the Federal Uni-
versity of Para´. All animals were housed under standard
conditions with food and water available ad libitum. All ex-
perimental procedures were carried out in accordance with
EU Directive 2010/63/EU for animal experiments UK and
animals (Scientific Procedures) Act 1986 and associated
guidelines as well as with the Principles of laboratory animal
care [22], under license from the Ethics Committee on
Experimental Animals of the Federal University of Para´. All
eﬀorts were made to avoid animal suﬀering and distress.
2.2. The Experimental Model of Excitotoxic Injury. In our
previous studies, we have characterized the present model
of NMDA-induced excitotoxic injury in both the brain [3]
and the spinal cord [5, 23]. In short, the animals were deeply
anesthetized with an intraperitoneal injection of a mixture of
Ketamine Chlorhydrate (90mg/kg) and Xylazine Chloridrate
(10mg/kg) and positioned in a stereotaxic apparatus. A
thermal blanket was used to maintain body temperature
within the physiological range with the help of a rectal
thermometer. After craniotomy, 80 nmol of NMDA (Sigma-
Aldrich, St. Louis, MO, USA) in 1 μL of sterile saline were
injected into the left motor cortex over a period of 2min
using a glass capillary micropipette (n = 8 per survival time).
The pipette was left in place for 3 minutes before being
slowly withdrawn. Control animals were injected with the
same volume of sterile saline (n = 5 per survival time). We
used the following stereotaxic coordinates for the injection
(in millimeters relative to bregma): 2.3mm lateral; 1.2mm
posterior; 0.5mm below the pial surface. To allow the poster-
ior identification of the injection site, a small amount of
colanyl blue was added to the injected solutions. After sur-
gery, animals were allowed to rest in their cages with water
and food ad libitum until postlesion days 1 and 4.
2.3. Harvest and Chemical Composition of the Copaiba Oil-
Resin. The investigated oleo-resin was obtained by research-
ers from the Brazilian Agricultural Research Corporation
(EMBRAPA) following the International Guidelines sug-
gested by the World Health Organization (WHO) [24]. The
COR was obtained by artificial exudation, through holes
made in the trunk of the Copaifera reticulata Ducke tree.
Two holes were made in the studied tree close to the trunk
center in two diﬀerent points (about 1m and 1.5m from the
ground) using a 2 cm in diameter and 45 cm long drill. After
the oleoresin harvest, both holes were plugged with a 3/4
diameter and 10 cm long tube in order to allow normal accu-
mulation of the oleoresins. Copaifera tree was located in the
experimental campus of EMBRAPA, in the district of Belt-
erra, State of Para´, Brazil. The Copaifera tree has exsiccate
kept in the West Amazon EMBRAPA’S IAN Herbarium
(Bele´m-Para´-Brazil) under number 183939.
The chemical composition of the COR was obtained by
chromatographic analysis according to protocol published
elsewhere [25]. A GC-MS equipment, in INCOSE Finnigan
Mat XL system, equipped with silica capillary column DB-
5MS (30 cm× 0.25mm, 0.25m film thickness) was used with
the following operating conditions: carrier gas: helium at
linear velocity of 32 cm/s (measured at 100◦C); type of injec-
tion: “splitless” (1mL of a solution 2 : 1000 hexane); injector
temperature and detector: 250◦C temperature program:
60◦C−240◦C (3◦C/min); MS: electron impact, 70 eV; source
temperature of ions and connecting pieces: 180◦C. The com-
ponents were identified by comparing their mass spectra and
retention indices (RIs) with those of standard substances, the
existing system libraries, and with literature data [26]. The
IR was obtained using the homologous n-alkanes.
The quantification of components was obtained by GC,
HP5890-II, equipped with flame ionization detector (FID)
and coupled to a HP3396 integrator-II under the same oper-
ating conditions, except that the carrier gas was hydrogen.
Using this procedure, it was possible to obtain COR samples
with high purity. The chemical composition of COR used in
this investigation is shown in Table 1.
2.4. Treatment with Oil-Resin of Copaifera reticulata Duke.
The COR was diluted in 5% Tween in sterile saline. Animals
were treated with a single dose of COR (400mg/kg, i.p.) soon
after surgery (Group 1, n = 8) or with two daily doses
(200mg/kg, i.p) for 3 days (Group 2, n = 8) postinjury.
Control animals were treated with vehicle only (n = 5).
Animals from Groups 1 and 2 were perfused at 1 and 4 days
after NMDA injection, respectively. These survival times
were chosen because in our previous studies we have shown
that the maximum numbers of neutrophils and activated
macrophage/microglia in the damaged CNS occur at 1 and
4–7 days following NMDA injection [3, 5, 23]. The COR
dose was chosen based on previous studies, which have
shown that COR treatment at a 400mg/kg dose induces a
conspicuous decrease on both neutrophilic infiltration and
lipoperoxidation following acetic-acid-induced colitis in
adult rats [18].
2.5. Perfusion and Histological Analysis. After the specified
survival times, animals were deeply anesthetized with an
overdose of Ketamine/Xylazine and perfused transcardially
with 0.9% heparinized saline followed by 4% paraformalde-
hyde in 0.1M phosphate buﬀer (PB), pH 7.4. The brains were
removed from the skull, washed in 0.1MPB for 5 minutes,
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Table 1: Composition of the copaiba’s oleoresin used in the present
study revealed by gas chromatography.
Component Percentage (%)
δ-elemene 0.2
cyclosativene 0.9
α-copaene 0.5
δ-elemene 0.2
cyclosativene 0.9
α-copaene 0.5
β-elemene 3.2
α-gurjunene 0.7
β-caryophyllene 37.3
trans-α-bergamotene 9.0
aromadendrene 0.9
epi-β-santalene 0.1
α-humulene + (E)-β-farnesene 5.4
β-chamigrene 1.0
γ-gurjunene 0.6
γ-curcumene 0.6
β-selinene 4.8
α-selinene 3.0
(Z)-α-bisabolene 1.8
α-bulnesene 2.2
β-bisabolene 14.5
β-curcumene 0.4
β-sesquiphelandrene 1.2
(E)-γ-bisabolene 1.4
caryophyllene oxide 0.1
epi-β-bisabolol 0.1
β-bisabolol 0.2
and cryoprotected by immersion in increasing concentra-
tions of sucrose solution. Coronal sections were obtained
using a cryostat (Carl Zeiss Microm, Germany). Sections
were collected onto gelatinized slides over microtomy and air
dried for 24 h. After, slides were stored at−20◦C for posterior
analysis.
2.6. Histopathological Analysis and Immunohistochemistry.
The lesion area was visualized in coronal sections (20 and
50 μm thick) stained with cresyl violet. The site of NMDA in-
jection was recognized by the presence of colanyl blue and
through the tissue pallor associated with loss of cell bodies.
In order to analyze both neutrophil infiltration and mi-
croglial activation, we resorted to standard immunohisto-
chemical procedures. Neutrophils were labeled using the
polyclonal antibodyMBS-1 (1 : 1000), which recognizes epit-
opes present on the majority of neutrophil populations (a
kind gift of Professor Victor Hugh Perry, CNS Inflammation
Group, University of Southampton, UK). Activated mi-
croglia/macrophages were labeled using the antibody ED1
(1 : 500, Serotec, UK), which binds to an epitope on the lyso-
somal membrane of activated macrophages and microglia
[27].
2.7. Labeling Protocol. The slide-mounted sections were
removed from the freezer, kept in an oven at 37◦C for 30
minutes and rinsed in 0.1M phosphate buﬀer saline (PBS)
for 5min. To improve labeling intensity, sections were treated
with 0.2M boric acid (pH 9.0) previously heated to 65◦C
for 25min. This temperature was maintained constant over
the treatment period. Sections were allowed to cool down
for about 20min and incubated under constant agitation in
an 1% hydrogen peroxide solution in methanol for 20min.
Sections were then rinsed in 0.05% PBS/Tween (Sigma Com-
pany, USA) solution for 5min for three times and incubated
with 10% normal goat (MBS-1) or horse (ED1) serum in
PBS for 1 h.Without further rinsing, sections were then incu-
bated overnight with the primary antibody in PBS, rinsed
in PBS/Tween solution for 5min (3 times), and incubated
with biotinylated goat anti-rabbit (MBS-1 antibody) or horse
anti-mouse (ED1 antibody) secondary antibodies (Vector
Laboratories, USA) diluted at 1 : 200 or 1 : 500 in PBS, respec-
tively, for 2 hs. As a negative control, normal sera, rather the
primary antibody, were used in some sections. Sections were
rinsed again for 5min (three times) and incubated in the
avidin-biotin-peroxidase complex (ABC Kit, Vector Labora-
tories, USA) for 2 hs. Sections were rinsed four times (5min
each) and revealed with DAB [23]. After the DAB reaction,
sections were rinsed two times (5min each) in 0.1MPB,
dehydrated, and coverslipped with Entellan (Merck, Ger-
many). Some sections were counterstained with cresyl violet.
2.8. Qualitative and Quantitative Analyses. All sections were
initially surveyed by light microscopy. Illustrative images
from all experimental groups were obtained with a digital
camera (Nikon Coolpix 950E) attached to a microscope
(Nikon AFX-DX Optiphot-2).
We used coronal sections containing the damaged motor
cortex to establish the areal density of neutrophils and acti-
vated macrophages/microglia (MBS-1 and ED1+ cells/mm2)
using a 0.0665mm2 square graticule attached to the micro-
scope eyepiece (objective 40x). We counted 3 fields per
section and 3 sections/animal for all experimental groups.
The regions of interest had the highest cell density along
a line passing through the lesion center (central field), and
2 additional fields were chosen at 1mm intervals (1mm
medially and 1mm laterally).
We used the Student’s t-test for independent samples for
the comparison between experimental and control groups,
with significance level set at P < 0.01. Average values were
expressed as mean ± S.E.M. All statistical analyses were done
using the software Biostat [28].
3. Results
3.1. Excitotoxic Damage Induced by NMDA Injection. Mi-
croinjections of 80 nmol of NMDA into the motor cor-
tex of adult rats induced conspicuous tissue damage and
inflammatory response at 1 day alter injection, as revealed
by cresyl violet staining (Figures 1(a)-1(b)). Damage was
characterized by tissue pallor, necrosis, and cavitation con-
comitant with intense infiltration of polymorphonuclear
cells (Figures 1(a)-1(b)). The presence of neutrophils in
the damaged tissue was confirmed by immunohistochem-
istry (Figures 2(a)-2(b)). Massive neutrophilic infiltration
(MBS-1+ cells) was observed in the motor cortex at 1 day
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Figure 1: COR treatment eﬀects on gross histopathology at 1 day following NMDA injection into the rat motor cortex, as revealed by
cresyl violet staining. Animals treated with 5% tween (a-b) or 400mg/kg of COR (c-d). COR treatment reduced polymorphonuclear cell
infiltration and tissue loss (c-d) compared to vehicle animals (a-b). Arrows point to polymorphonuclear cells (d). Asterisks indicate the
excitotoxic necrotic center. Scale bars: (a–c) (300 μm); (b–d) (50 μm).
following NMDA injection, as confirmed by quantitative
analysis (Figure 2(e)).
There was an increase in the necrotic area at 4 days after
NMDA injection (Figures 3(a)-3(b)). Cavitations were more
prominent in the damaged motor cortex (Figures 3(a)-3(b)).
The inflammatory response was characterized by a dra-
matic increase in the number of mononuclear cells in
and around the lesion site, as revealed by cresyl violet
staining (Figures 3(a)-3(b)). Cell identity was confirmed by
immunohistochemistry against ED1, a specific marker of
activated microglia/macrophages (Figures 4(a)-4(b)), and
confirmed by quantitative analysis (Figure 4(e)).
The neuropathological results described above are in
agreement with previous studies by our own group [3, 23]
and other authors [29] using the experimental model of
excitotoxic damage using NMDA microinjections.
3.2. Copaiba Oil-Resin Treatment Induces Tissue Preserva-
tion and Reduces Neutrophil Recruitment and Microglia/
Macrophage Activation following Acute Motor Cortex Damage.
In order to investigate the eﬀect of COR treatment on tissue
preservation and inflammatory response following acute
motor cortex damage, we treated NMDA-injected animals
with either COR or vehicle solution. There was less tissue
damage in NMDA-injected animals treated with COR com-
pared to vehicle animals both at 1 day (Figures 1(c)-1(d))
and 4 days alter injury (Figures 3(c)-3(d)). Tissue necrosis
and cavitation were less evident in COR-treated animals (Fig-
ures 1(c)-1(d) and 3(c)-3(d)) compared to vehicle animals
(Figures 1(a)-1(b) and 3(a)-3(b)).
COR treatment also induced a conspicuous decrease
in the number of both polymorphonuclear (Figures 1(c)-
1(d) and 2(c)-2(d)) and mononuclear cells (Figures 3(c)-
3(d) and 4(c)-4(d)) in the injured motor cortex, compared
to vehicle animals ( Figures 1(a)-1(b) and 4(a)-4(b)). These
results were confirmed by quantitative analysis (Figures 2(e)
and 4(e), P < 0.01). The average numbers of neutrophils
and activated microglia/field were 55.56 (±4.00) and 34.06
(±3.50) for animals treated with COR and the vehicle solu-
tion, respectively (Figure 2(e)). The corresponding numbers
for activated microglia/macrophages were 75.59 (±3.00) and
28.70 (±2.14), respectively (Figure 4(e)). The data analysis
shows that there was a 39% reduction of neutrophilic
infiltration and a 62% decrease on microglial activation
(Figure 4(e)).
4. Discussion
We investigated the eﬀects of COR treatment on tissue
preservation and inflammatory response following NMDA-
induced excitotoxic damage to the motor cortex of adult
rats. This experimental model of acute CNS damage is well
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Figure 2: COR treatment reduces neutrophil infiltration at 1 day following cortical damage, as revealed by antineutrophil immunohisto-
chemistry. Animals treated with 5% tween (a-b) or 400mg/kg of COR (c-d). COR treatment reduced neutrophil infiltration (c-d) compared
to vehicle animals (a-b), as confirmed by quantitative analysis (e, P < 0.01, Student’s t-test). Arrows point to MBS-1+ cells (neutrophils).
Asterisks indicate the excitotoxic necrotic center. Scale bars: (a–c) (300 μm); (b–d) (50 μm).
established [3, 5, 30] and present neuropathological findings,
including tissue necrosis and an intense inflammatory
response. COR treatment reduced tissue necrosis and cavita-
tion as well as neutrophil recruitment and microglia/macro-
phage activation in NMDA-injected animals, compared to
the control group.
COR has been traditionally used in Brazilian folk medi-
cine as a healing and anti-inflammatory agent and recent
investigations confirmed these eﬀects in peripheral tissues
both in vitro and in vivo [17–19]. Nevertheless, there are no
published reports on the COR eﬀects during acute damage
to the CNS.
A single intraperitoneal application of 400mg/kg of COR
from Copaifera reticulataDuke reduced damage to the motor
cortex and neutrophil infiltration in about 39% at 1 day
alter injury. This is in agreement with previous studies on
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Figure 3: COR treatment eﬀects on gross histopathology at 4 days following NMDA injection into the rat motor cortex, as revealed by cresyl
violet staining. Animals treated with 5% tween (a-b) or 400mg/kg of COR (c-d). COR treatment reduced mononuclear cell infiltration and
tissue cavitation (c-d) compared to vehicle animals (a-b). Arrows point to mononuclear cells (d). Asterisks indicate the excitotoxic necrotic
center. Scale bars: (a–c) (300 μm); (b–d) (50 μm).
peripheral tissues [17–19]. It has been shown that COR
treatment (200 and 400mg/kg) reduces neutrophilic infil-
tration and colonic mucosal damage following acetic-acid-
induced colitis in rats [18]. In this study, COR treatment
also reduced myeloperoxidase activity, further confirming
the specific actions of COR treatment on neutrophil recruit-
ment [18]. Anti-inflammatory eﬀects of COR were also
observed following experimental pleurisy [17] and skin flap
reperfusion-ischemia [31] in rodents.
Antineutrophilic eﬀects of COR may partly explain the
neuroprotection found in the present study. It has been
shown that neutrophil recruitment is associated with damage
exacerbation following experimental acute neural disorders,
including SCI [9, 14] and stroke [8] as well as following
human diseases [11, 32]. Inhibition of neutrophil elastases
induces neuroprotection and improves functional recovery
following rat spinal cord compression [9]. Moreover, inhibi-
tion of neutrophil recruitment by an anti-P-selectin mono-
clonal antibody renders similar results following SCI [14].
In addition, a recent investigation suggests that microglia
may be beneficial by direct engulfment of both apoptotic and
viable neutrophils following experimental ischemia [8].
COR treatment reduced in more than 60% the levels of
microglia/macrophage activation following acute cortical
damage. This level of microglia/macrophage inhibition is
superior to the one obtained by using minocycline, a classical
microglia/macrophage inhibitor [10, 30]. This finding has
also important neuroprotective implications, as it has been
shown that overactivated macrophage/microglia contribute
to tissue injury following CNS diseases [10, 16, 30], even in
humans [15].
Inhibition of microglial activation with minocycline
induces a considerable decrease in both cortical and striatal
infarct area following MCAO in rats [10]. Minocycline treat-
ment protects oligodendrocytes, attenuates axonal degener-
ation, and improves functional outcome following SCI [33].
We have also shown that minocycline treatment protects
the white matter following NMDA-induced striatal damage
[30]. A recent study has shown that microglial activation is a
long-lasting phenomenon following human stroke and may
contribute to the physiopathology of this important disease
[34].
The mechanisms by which COR exerts its anti-inflam-
matory and neuroprotective eﬀects are presently unknown.
As discussed above, attenuation of neutrophil recruitment
and inhibition ofmacroglia/macrophage activationmay con-
tribute to neuroprotection. These inflammatory cells may
release oxygen radicals, proteases, and proinflammatory
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Figure 4: COR treatment reduces mononuclear cell infiltration at 4 days following cortical damage, as revealed by anti-ED1
immunohistochemistry. Animals treated with 5% tween (a-b) or 400mg/kg of COR (c-d). COR treatment reduced microglia/macrophage
activation (ED1+ cells) (c-d), compared to vehicle animals (a-b), as confirmed by quantitative analysis (e, P < 0.01, Student’s t-test). Arrows
point to ED1+ cells (activated microglia/macrophages). Asterisks indicate the excitotoxic necrotic center. Scale bars: (a–c) (300 μm); (b–d)
(50 μm).
cytokines, like tumor necrosis factor alpha (TNF-α), con-
tributing to tissue damage [35, 36]. CORmight modulate the
release of these proinflammatory substances, which would
contribute to neuroprotection.
COR chemical composition comprises several sesquit-
erpenes, including β-caryophyllene, α-copaene, and α-hu-
mulene, as revealed by chromatographic studies [17, 19, 25].
β-caryophyllene is the main sesquiterpene present in copaiba
oil, comprising 40% to 57% of COR composition, depending
on the Copaifera specie [19]. In Copaifera reticulata Ducke,
the species used in the present study, β-caryophyllene
comprises about 40% of COR composition [19], which is in
agreement with our own chromatographic studies.
β-caryophyllene is a putative candidate as the main anti-
inflammatory COR compound. In vitro studies suggest that
β-caryophyllene is a dietary cannabinoid with important
anti-inflammatory eﬀects through the inhibition of cannabi-
noid type-2 (CB(2)) receptor [37]. In vitro, this plant
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sesquiterpene binds selectively to CB(2) receptor inhibit-
ing proinflammatory pathways, including toll-like receptor
complex CD14/TLR4/MD2, which normally leads to the
expression of IL-1β, IL-6, IL-8, and TNF-α 9 [37]. In vivo,
oral treatment with β-caryophyllene decreases inflammation
in a mouse model of colitis [38]. It is possible that that
a downstream mechanism of β-caryophyllene might be the
decrease of TNF-α release by inhibition of CB-2 cannabinoid
receptor [39]. In addition, other sesquiterpenes may be
involved on the mechanisms underlying the COR anti-
inflammatory eﬀects. α-humulene, other sesquiterpene
present in the COR, reduces eosinophil recruitment and
release of several proinnflammatory substances in an exper-
imental model of airways allergic inflammation [40] or
following LPS injection in the rat paw [41]. It is possible that
diﬀerent sesquiterpenes interact synergistically contributing
to the anti-inflammatory eﬀects of COR observed in the
present study.
5. Conclusions
In this study, we provide the first experimental evidence
that COR is an anti-inflammatory and neuroprotective agent
following an acute damage to the CNS. COR sesquiterpenes,
including β-caryophyllene, are likely responsible for the anti-
inflammatory and neuroprotective eﬀects here described.
This hypothesis should be investigated in further studies
using molecular biology techniques in diﬀerent in vitro and
in vivo experimental models of CNS disorders. Considering
that β-caryophyllene is already an FDA-approved food
additive, these natural sesquiterpenes have an enormous
potential to decrease the burden of inflammation-induced
damage following neural and nonneural diseases.
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